Northway Biotech
Dr. Andre Markmann has extensive experience in the biotech industry, particularly in business development and project management. Dr. Andre has held various roles at different companies throughout their career. From 2014 to present, Dr. Markmann has worked as the Vice President of Business Development at Northway Biotech, where they offer integrated services for biotechnological productions. Prior to that, from 2012 to 2014, they served as the Business Development Director for Europe at Patheon/ DSM Biosolutions, focusing on process development and contract manufacturing of recombinant proteins and fermentation-based small molecules. From 2008 to 2011, they held the position of Director of Custom Synthesis & Biotechnology at Midas Pharma, and from 2004 to 2008, they worked as a Project Manager in the same company. Earlier in their career, from 2002 to 2004, Dr. Markmann was a Research Scientist at Sanofi/ Aventis Pharma.
Dr. Andre Markmann received a Prediploma in Biochemistry from Bielefeld University in 1995. Dr. Andre then went on to obtain their Ph.D. in Biochemistry from the University of Muenster, completing their studies in 2001.
This person is not in any offices
Northway Biotech
Northway Biotech is a Contract Development and Manufacturing Organization (CDMO) located in Waltham, MA, USA, and Vilnius, Lithuania, EU. Extensive expertise in drug substance and drug product development, as well as GMP compliant manufacturing, makes us exceptionally well-versed in all aspects of the biopharmaceutical value chain – from gene to drug manufacturing in microbial and mammalian expressions systems. Our customers appreciate our ability to react rapidly to unexpected project changes, adjusting timelines, and availability of additional capabilities to meet our customers' evolving needs. We are deeply invested in providing high-quality, world-class contract development and manufacturing services with vast flexibility and responsiveness backed by a strong foundation in science and technology innovation. Northway Biotech end-to-end services include: Cell Line (Mammalian & Microbial) Development Analytical Methods Development Formulation Development Upstream & Downstream Process Development (USP & DSP) cGMP Manufacturing of Biologics & Biosimilars (Drug Substance, Drug Product) cGMP Master and Working Cell Bank Manufacturing cGMP pDNA Manufacturing Fill & Finish (F&F) Quality Assurance, Quality Control, and Regulatory CMC Support